prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, Procedure Date: Accession Date: CLINICAL DATA: breast mass. IOC/FROZEN: A1FS: Infiltrating carcinoma. reported at. GROSS EXAMINATION: A. "Left Breast Mass, One Stitch Lateral, Two Stitches Anterior (Frozen Section)". The. specimen is received fresh. for frozen section designated "Left Breast Mass, One Stitch Lateral, Two Stitches. Anterior". and consists of a 9.5 X 6.3 X 4.0 cm portion of tan-yellow fibroadipose tissue. The. posterior margin is inked black. and the anterior margin is inked blue. Sectioning shows a 3.4 x 2.8 x 2.5 cm solid ill-. defined tan-white infiltrating. mass which extends very close to the anterior and posterior inked margins. Representative sections are submitted. in twelve cassettes. A1FS- frozen section remnant; A2-A4- mass and posterior margin;. A5, A6- mass and anterior. margin; A7- inferior margin; A8- superior margin; A9, A10- medial margin; A11, A12-. lateral margin. Placed in formalin: Removed from formalin: Fixation time: 56 hours and 5 minutes. B. "Left Breast Mass (B), One Stitch Lateral, Two Stitch Anterior". The specimen is. received in formalin designated "Left Breast Mass (B), One Stitch Lateral, Two Stitch. Anterior" and consists of a 6.8 x. 4.2 X 2.7 cm portion of tan-yellow fibroadipose tissue with sutures as described. The. lateral margin is inked black,. the medial margin is inked blue, the superior margin is inked yellow, and the inferior. margin is inked orange and. the posterior margin is inked green. Sectioning shows an ill-defined area of grey-white. induration measuring. approximately 2.0 X 1.5 X 1.5 cm located in the posterior portion of the specimen, and. extending close to the. inferior, lateral and medial margins. The remaining specimen is composed primarily of. pale yellow lobular adipose. tissue. Representative sections are submitted in fourteen cassettes. B1-B6- ill-defined. area of induration with. lateral, medial and inferior margins; B7, B8- posterior margin; B9- B11 - superior margin;. B12- anterior margin;. B13, B14- additional sections of breast tissue with lateral and medial margins. Placed in formalin: Removed from formalin: Fixation time: 7 hours and 20minutes. C. "Skin Tags". The specimen is received in formalin designated "Skin Tags" and. consists of. multiple grey-brown skin fragments measuring up to 0.5 cm. Submitted in toto in one. cassette. Placed in formalin: Removed from formalin: Fixation time: 7 hours and 20 minutes. DIAGNOSIS: A. Left breast mass, excision: Infiltrating ductal carcinoma of the breast; see synoptic report. B. Left breast mass: Few microscopic foci of atypical ductal hyperplasia, with marked fibrocystic changes. Residual carcinoma is not identified. C. Skin tags: Skin tags, benign. SYNOPTIC REPORT: INFILTRATING BREAST CANCER. Procedure: Excision without wire-guided localization. Lymph Node Sampling: Not performed. Specimen Laterality: Left. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma with areas of. mucinous differentiation. Tumor Size: 3.4 cm in greatest diameter. Histologic Grade: Glandular/Tubular Differentiation: 3. Mitotic Rate: 3. Nuclear Pleomorphism: 3. Overall Grade: 3 of 3. Tumor Focality: Single focus of invasive carcinoma. Ductal Carcinoma In Situ. Few foci of ductal carcinoma in situ present; extensive intraductal component not. identified. Margins: Deep surgical margin: Positive for invasive carcinoma (one low power field). Anterior surgical margin: Negative for infiltrating carcinoma (infiltrating carcinoma. reaches within 0.5 mm of. the anterior surgical margin, in two low power fields). Lymph Nodes: Not submitted. Lymph-Vascular Space Invasion: Present. Pathologic Staging: Primary Tumor: pT2. Regional Lymph Nodes: pNX. Distant Metastasis: Not Applicable. COMMENT: Prognostic markers are pending; a supplemental report will follow. CPT Code: 88307 X 2, 88305, 88331.

expanded version (tokens=1377) : 
 The breast pathology report includes the following information:
- Histological classification: Infiltrating ductal carcinoma with areas of mucinous differentiation.
- Subtype: LumB
- Necrosis: Not mentioned.
- Tumor infiltrating lymphocytes: Not mentioned.
- Histological grade: Histologic grade is 3 (Glandular/tubular differentiation, Mitotic rate, Nuclear pleomorphism).
- Nuclear grade: Not mentioned specifically, but the overall histologic grade is 3, which indicates high-grade cancer.
- Lymphovascular invasion: Present.
- Calcification: Not mentioned.
- Receptor status: Not mentioned.
- IHC testing results: Not mentioned.
- Other ancillary testing results: Not mentioned.

Additional details from the report:
- The excision was performed without wire-guided localization.
- A few microscopic foci of atypical ductal hyperplasia with marked fibrocystic changes were also identified.
- The tumor is unifocal and measures 3.4 cm in greatest diameter.
- The surgical margins were evaluated and found to be positive for invasive carcinoma at the deep margin, and within 0.5 mm of the anterior margin.
- Lymph node sampling was not performed.
- Prognostic markers are pending and a supplemental report will follow.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1531) : 
 The excised left breast mass is unifocal and measures 3.4cm in greatest diameter. It is a high-grade LumB subtype, Invasive ductal carcinoma with areas of mucinous differentiation. Histologic grade is 3, with infiltrating margins and lymphovascular invasion present. A few microscopic foci of atypical ductal hyperplasia were also identified. No receptor status, calcification nor IHC testing results are mentioned, with prognostic markers pending. Lymph node sampling was not performed.

